Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 17.21% is 66% above its 5-year average of 10.38%, around the middle of its 5-year range (-24.03%–47.31%).
62.58% above its 12-month average of 10.59%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.71%.
OPERATING MARGIN
17.21%
OPERATING MARGIN AVG TTM
10.59%
OPERATING MARGIN AVG 3Y
24.29%
OPERATING MARGIN AVG 5Y
10.38%
OPERATING MARGIN AVG 10Y
-5.73%
OPERATING MARGIN AVG 15Y
-7.72%
OPERATING MARGIN AVG 20Y
-7.32%
CURRENT VS TTM AVG
+62.58%
CURRENT VS 3Y AVG
-29.13%
CURRENT VS 5Y AVG
+65.77%
CURRENT VS 10Y AVG
+400.46%
CURRENT VS 15Y AVG
+322.85%
CURRENT VS 20Y AVG
+335.02%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$7.23B
Operating Margin
-40.47%
TTM Avg
-53.92%
3Y Avg
-55.65%
5Y Avg
-41.65%
Market Cap
$7.61B
Operating Margin
-92.94%
TTM Avg
-50.55%
3Y Avg
-48.57%
5Y Avg
-48.57%
Market Cap
$7.65B
Operating Margin
25.61%
TTM Avg
21.87%
3Y Avg
15.23%
5Y Avg
12.87%
Market Cap
$6.68B
Operating Margin
13.46%
TTM Avg
14.22%
3Y Avg
14.89%
5Y Avg
15.72%
Market Cap
$6.62B
Operating Margin
4.50%
TTM Avg
4.35%
3Y Avg
-1.93%
5Y Avg
-10.04%
Market Cap
$6.61B
Operating Margin
-362.95%
TTM Avg
-1052.99%
3Y Avg
-3382.94%
5Y Avg
-3698.56%
Market Cap
$7.80B
Operating Margin
-695.44%
TTM Avg
-1799.08%
3Y Avg
-2632.66%
5Y Avg
-1827.24%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alkermes plc (ALKS) | $7.17B | 17.21% | 10.59% | 24.29% | 10.38% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.23B | -40.47% | -53.92% | -55.65% | -41.65% |
| Immunovant, Inc. (IMVT)vs › | $6.86B | 0.00% | 0.00% | 0.00% | 0.00% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | -92.94% | -50.55% | -48.57% | -48.57% |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 25.61% | 21.87% | 15.23% | 12.87% |
| Chemed Corporation (CHE)vs › | $6.68B | 13.46% | 14.22% | 14.89% | 15.72% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.62B | 4.50% | 4.35% | -1.93% | -10.04% |
| GRAIL Inc. (GRAL)vs › | $6.61B | -362.95% | -1052.99% | -3382.94% | -3698.56% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.80B | -695.44% | -1799.08% | -2632.66% | -1827.24% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.50B | 12.93% | 11.47% | 6.80% | 6.51% |
Gross Margin
84.6%
Operating Margin
17.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.71% |
| 2026-03-31 | -12.29% |
| 2025-12-31 | 15.11% |
| 2025-09-30 | 22.60% |
| 2025-06-30 | 23.80% |
| 2025-03-31 | 4.50% |
| 2024-12-31 | 37.84% |
| 2024-09-30 | 27.70% |
| 2024-06-30 | 27.53% |
| 2024-03-31 | 12.36% |
| 2023-12-31 | 47.31% |
| 2023-09-30 | 23.41% |
| 2023-06-30 | 45.56% |
| 2023-03-31 | -3.82% |
| 2022-12-31 | -6.76% |
| 2022-09-30 | -24.03% |
| 2022-06-30 | -12.47% |
| 2022-03-31 | -9.54% |
| 2021-12-31 | 0.73% |
| 2021-09-30 | -6.68% |
| 2021-06-30 | 1.46% |
| 2021-03-31 | -6.54% |
| 2020-12-31 | -10.97% |
| 2020-09-30 | -4.03% |
| 2020-06-30 | -13.60% |
| 2020-03-31 | -15.18% |
| 2019-12-31 | -2.41% |
| 2019-09-30 | -21.01% |
| 2019-06-30 | -12.84% |
| 2019-03-31 | -34.07% |
| 2018-12-31 | 0.01% |
| 2018-09-30 | -14.94% |
| 2018-06-30 | -0.03% |
| 2018-03-31 | -27.49% |
| 2017-12-31 | 2.12% |
| 2017-09-30 | -17.64% |
| 2017-06-30 | -20.34% |
| 2017-03-31 | -36.95% |
| 2016-12-31 | -11.02% |
| 2016-09-30 | -33.91% |
| 2016-06-30 | -24.14% |
| 2016-03-31 | -49.04% |
| 2015-12-31 | -41.11% |
| 2015-09-30 | -50.71% |
| 2015-06-30 | -34.70% |
| 2015-03-31 | -16.94% |
| 2014-12-31 | -8.96% |
| 2014-09-30 | -20.46% |
| 2014-06-30 | -14.88% |
| 2014-03-31 | -12.21% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | -2.77% |
| 2013-06-30 | 9.76% |
| 2013-03-31 | 11.62% |
| 2012-12-31 | 18.59% |
| 2012-09-30 | 4.37% |
| 2012-06-30 | 21.11% |
| 2012-03-31 | -44.20% |
| 2011-12-31 | -3.95% |
| 2011-09-30 | -16.34% |
| 2011-06-30 | -22.43% |
| 2011-03-31 | -26.60% |
| 2010-12-31 | -27.08% |
| 2010-09-30 | -14.28% |
| 2010-06-30 | -30.96% |
| 2010-03-31 | -48.21% |
| 2009-12-31 | -14.12% |
| 2009-09-30 | -17.08% |
| 2009-06-30 | -21.10% |
| 2009-03-31 | -30.25% |
| 2008-12-31 | 72.52% |
| 2008-09-30 | 8.14% |
| 2008-06-30 | 39.37% |
| 2008-03-31 | -28.47% |
| 2007-12-31 | -4.67% |
| 2007-09-30 | 11.23% |
| 2007-06-30 | 15.63% |
| 2007-03-31 | 6.52% |
| 2006-12-31 | 5.05% |
| 2006-09-30 | 6.30% |
| 2006-06-30 | -0.37% |
| 2006-03-31 | 12.22% |
| 2005-12-31 | 8.47% |
| 2005-09-30 | 29.66% |
| 2005-06-30 | -41.28% |
| 2005-03-31 | -55.11% |
| 2004-12-31 | -35.07% |
| 2004-09-30 | -79.43% |
| 2004-06-30 | -321.02% |
| 2004-03-31 | -150.58% |
| 2003-12-31 | -182.99% |
| 2003-09-30 | -354.89% |
| 2003-06-30 | -597.77% |
| 2003-03-31 | -135.62% |
| 2002-12-31 | -89.59% |
| 2002-09-30 | -333.58% |
